Acute Myeloid Leukemia and Myelodysplastic Syndromes | Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes – A Review of the 2022 ASCO Annual Meeting and EHA Congress
Research To Practice | Oncology Videos · Dr. Neil Love
July 27, 20221h 1m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Richard Stone, including the following topics:
- Introduction: RATIFY trial in perspective (0:00)
- Treatment with FLT3 inhibitors (7:00)
- Anti-CD47 antibody: Magrolimab (23:04)
- Anti-TIM-3 antibody: Sabatolimab (31:23)
- CAR T-cell therapy for acute myeloid leukemia (34:53)
- Targeted therapy with IDH inhibitors (37:31)
- New myelodysplastic syndromes classification system (41:20)
- Hypomethylating agents/venetoclax (45:11)
- CPX-351 (49:14)
- Other key data sets (50:59)